THE HERALD SCOTLAND: Patients with heart failure could soon be treated at home following a world-first NHS trial at a Scots hospital.
SQ Innovation, Inc
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation
SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart failure.